Impedimed Limited (AU:IPD) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
ImpediMed Limited has announced a change in director Ms. Janelle Delaney’s interests in the company, with an increase of 152,468 ordinary shares acquired indirectly. This adjustment results from the issuance of shares in lieu of 30% of her director fees for the quarter ending September 2024. The transaction reflects a strategic decision to align director compensation with shareholder interests.
For further insights into AU:IPD stock, check out TipRanks’ Stock Analysis page.
